FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

10 letters match. Newest first.

  1. Root Bioscience Brands, LLC dba Naternal

    FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.

    High risk
  2. Discover Health, LLC d/b/a Discover CBD and Strain Snobs

    FDA warns Discover Health over unapproved CBD, CBG, HHC, and Delta-8 THC drugs, unsafe CBD/Delta-8 foods, and unapproved animal drugs.

    High risk
  3. Shot of Joy LLC

    FDA warned Shot of Joy LLC that its kratom and kava products are unapproved new drugs marketed for opioid addiction and other conditions.

    High risk
  4. Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom

    FDA warned Nova Kratom that its kratom products are unapproved new drugs marketed to treat opioid addiction and withdrawal.

    High risk
  5. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  6. Klarity Kratom

    Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.

    High risk
  7. Kratom Exchange

    FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.

    High risk
  8. Omni Consumer Products LLC d/b/a YoKratom

    FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.

    High risk
  9. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  10. Rena's Organic

    U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.

    High risk